Article

Compliance likely an issue when amblyopia therapy fails

When treating a child with amblyopia, what steps do you take when the Pediatric Eye Disease Investigator Group (PEDIG) guidelines do not work? The first thing to consider is whether you're getting poor compliance with your therapy, said Lionel Kowal, MD, FRACOphth, FRACS, Ophthalmology Eye and Ear Hospital, Melbourne, Australia.

When treating a child with amblyopia, what steps do you take when the Pediatric Eye Disease Investigator Group (PEDIG)guidelines do not work? The first thing to consider is whether you're getting poor compliance with therapy, said LionelKowal, MD, FRACOphth, FRACS, Ophthalmology Eye and Ear Hospital, Melbourne, Australia.

With patching, for example, Dr. Kowal said documentation in parent-kept diaries tends to overestimate the actual patchingtime. That could explain why in some studies, 2 hours of patching yields the same therapeutic results as 6 hours.

"Parents don't like parading an obviously defective child," Dr. Kowal said. "They also don't like to be 'mean' to theirchildren. So it's a tough situation for everyone involved.

"Sometimes we find that the best way to get your therapy to work is to find a way to help parents maintain enthusiasm for thetask," he said.

Other measures to consider if you are following the PEDIG guidelines but are not achieving satisfactory results, according toDr. Kowal:

  • If you're already patching, try atropine.
  • If you're using atropine, try patching.
  • Look for missed organic factors.
  • Correct the patient's strabismus.
  • In severe cases, consider refractive surgery.

Finally, remember the parents. "You must find a way to keep the therapeutic environment alive," Dr. Kowal said.

Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Wendy Lee, MD, talks about functional oculoplastics and aesthetics at EnVision Summit 2025
1 expert is featured in this series.
Lana Rifkin, MD, uveitis committee chair at EnVision Summit 2025
© 2025 MJH Life Sciences

All rights reserved.